NGENF
Price
$1.55
Change
-$0.00 (-0.00%)
Updated
Nov 14 closing price
ZLDPF
Price
$115.06
Change
-$0.00 (-0.00%)
Updated
Nov 14 closing price
Ad is loading...

NGENF vs ZLDPF

Header iconNGENF vs ZLDPF Comparison
Open Charts NGENF vs ZLDPFBanner chart's image
NervGen Pharma
Price$1.55
Change-$0.00 (-0.00%)
Volume$133.35K
CapitalizationN/A
Zealand Pharma A/S
Price$115.06
Change-$0.00 (-0.00%)
Volume$106
CapitalizationN/A
NGENF vs ZLDPF Comparison Chart
Loading...
View a ticker or compare two or three
VS
NGENF vs. ZLDPF commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NGENF is a Hold and ZLDPF is a Hold.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (NGENF: $1.55 vs. ZLDPF: $115.06)
Brand notoriety: NGENF and ZLDPF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NGENF: 285% vs. ZLDPF: 9%
Market capitalization -- NGENF: $109.53M vs. ZLDPF: $8.2B
NGENF [@Biotechnology] is valued at $109.53M. ZLDPF’s [@Biotechnology] market capitalization is $8.2B. The market cap for tickers in the [@Biotechnology] industry ranges from $475.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NGENF’s FA Score shows that 0 FA rating(s) are green whileZLDPF’s FA Score has 2 green FA rating(s).

  • NGENF’s FA Score: 0 green, 5 red.
  • ZLDPF’s FA Score: 2 green, 3 red.
According to our system of comparison, ZLDPF is a better buy in the long-term than NGENF.

Price Growth

NGENF (@Biotechnology) experienced а -17.11% price change this week, while ZLDPF (@Biotechnology) price change was -3.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.93%. For the same industry, the average monthly price growth was -3.18%, and the average quarterly price growth was +1.55%.

Industries' Descriptions

@Biotechnology (-5.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
ZLDPF($8.2B) has a higher market cap than NGENF($110M). ZLDPF YTD gains are higher at: 106.757 vs. NGENF (-24.020).
NGENFZLDPFNGENF / ZLDPF
Capitalization110M8.2B1%
EBITDAN/AN/A-
Gain YTD-24.020106.757-22%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
ZLDPF: Fundamental Ratings
ZLDPF
OUTLOOK RATING
1..100
20
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
7
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
7
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

NGENF and

Correlation & Price change

A.I.dvisor tells us that NGENF and INO have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NGENF and INO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NGENF
1D Price
Change %
NGENF100%
-19.27%
INO - NGENF
23%
Poorly correlated
-3.64%
CYCC - NGENF
23%
Poorly correlated
-12.60%
GLSI - NGENF
22%
Poorly correlated
+1.80%
ZLDPF - NGENF
22%
Poorly correlated
-0.86%
SLDB - NGENF
22%
Poorly correlated
-4.50%
More

ZLDPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZLDPF has been loosely correlated with IMRN. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ZLDPF jumps, then IMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZLDPF
1D Price
Change %
ZLDPF100%
-0.86%
IMRN - ZLDPF
52%
Loosely correlated
-2.53%
MNMD - ZLDPF
32%
Poorly correlated
-0.06%
VICP - ZLDPF
28%
Poorly correlated
N/A
GLSI - ZLDPF
26%
Poorly correlated
+1.80%
PSTX - ZLDPF
24%
Poorly correlated
-2.13%
More